Bitter taste receptor agonist / Aversive agent

This page covers all Bitter taste receptor agonist / Aversive agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Bitter taste receptors (T2R family), Bitter taste receptors (T2Rs), particularly TAS2R family members, TAS2R (bitter taste receptors).

Targets

Bitter taste receptors (T2R family) · Bitter taste receptors (T2Rs), particularly TAS2R family members · TAS2R (bitter taste receptors)

Marketed (3)

• Intragastric denatonium benzoate · Universitaire Ziekenhuizen KU Leuven · Gastroenterology / Obesity / Safety
  Denatonium benzoate is a bitter-tasting compound administered intragastrically that triggers aversive taste responses to discourage accidental ingestion or promote satiety.
• Intraduodenal denatonium benzoate · Universitaire Ziekenhuizen KU Leuven · Gastroenterology
  Denatonium benzoate is a bitter-tasting compound administered intraduodenally that triggers taste receptors to elicit a protective reflex and modify gastrointestinal function.
• Intraduodenal quinine hydrochloride · Universitaire Ziekenhuizen KU Leuven · Diabetes
  Intraduodenal quinine hydrochloride acts as a bitter taste receptor agonist that stimulates local sensory pathways in the small intestine to modulate glucose homeostasis and metabolic function.

Patent intelligence

• bitter taste receptor agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates